14.02.2020 - 11:23 Uhr

Blue Orca's Short Selling Plan Failed Because the Quality China Medical System Can Withstand Severe Tests

HONG KONG, Feb 14, 2020 - (ACN Newswire) - While the world attention is on the fight against Coronavirus in China, Blue Orca is concerned about other things at the same time. This time, this foreign short selling agency aimed at a high-quality Chinese pharmaceutical company.